Therapeutic efficacies of isoniazid and rifampin encapsulated in lung- specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1211-1214

  Deol, Parampal ^a   Khuller, G K ^a   Joshi, K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMYLOPECTIN; CHOLESTEROL; ISONIAZID; LIPOSOME; PHOSPHATIDYLCHOLINE; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; HISTOPATHOLOGY; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TISSUE SPECIFICITY;

EID: 0030918970     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1211     Document Type: Article

References (21)

1. Alving, C. R., E. A. Steck, W. L. Chapman, Jr., V. B. Waits, L. D. Hendricks, G. M. Swartz, Jr., and W. L. Hanson. 1980. Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines and tetracyclines. Life Sci. 22:1021-1026.
2. Aoki, M., K. Kudoh, and T. Ohsato. 1968. Virulence of tubercle bacilli isolated from tuberculous patients in Japan. Rep. Med. Res. Probl. Jpn. Anti-Tuberc. Assoc. 16:7-15.
3. Brande, P. V. D., W. V. Steenbergen, G. Vervoort, and M. Demedts. 1995. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 152:1705-1708.
4. Cynamon, M. H., C. E. Swenson, G. S. Palmer, and R. S. Ginsberg. 1989. Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 33:1179-1183.
5. Davidson, P. T., and L. H. Quec. 1992. Drug treatment of tuberculosis - 1992. Drugs 43:651-673.
6. Deol, P., and G. K. Khuller. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim. Biophys. Acta, in press.
7. Gabizon, A., A. Sulkes, and T. Peretz. 1989. Liposome-associated doxorubicin: preclinical pharmacology and exploratory clinical phase, p. 391-402. In G. Lopez Berestein and I. Fidler (ed.), Liposomes in the therapy of infectious diseases and cancer. Alan R. Liss, New York, N.Y.
8. Horowitz, T. A., H. Barenholz, and A. Gabizon. 1992. In vitro cytotoxicity of liposome encapsulated doxorubicin dependence on liposome composition and drug release. Biochim. Biophys. Acta 1109:203-209.
9. Lopez-Berestein, G. R., R. Mehta, R. L. Hopfer, K. Mills, L. Kasi, K. Mehta, V. Fainstein, M. Luna, E. M. Hersh, and R. L. Juliano. 1983. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome encapsulated amphotericin B. J. Infect. Dis. 147:939-944.
10. Majumdar, S., D. Flasher, D. S. Friend, P. Nassos, D. Yajko, W. K. Hadley, and N. Duzgunes. 1992. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-Mycobacterium intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob. Agents Chemother. 36:2808-2815.
11. Medda, S., S. Mukherjee, N. Das, K. Naskar, S. B. Mahato, and M. K. Basu. 1993. Sugar-coated liposomes: a novel delivery system for increased drug efficacy and reduced drug toxicity. Biotechnol. Appl. Biochem. 17:37-47.
12. Mehta, R. T., R. L. Hopfer, L. A. Gunner, R. L. Juliano, and G. Lopez-Berestein. 1987. Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrob. Agents Chemother. 31:1897-1900.
13. Mehta, R. T., T. J. McQueen, A. Keyhani, and G. Lopez-Berestein. 1991. Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. J. Infect. Dis. 164:1003-1006.
14. Nightingale, S. D., S. L. Saletan, C. E. Swenson, A. J. Lawrence, D. A. Watson, F. G. Pilkiewicz, E. G. Silverman, and S. X. Cal. 1993. Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob. Agents Chemother. 37:1869-1872.
15. Orozco, L. C., F. O. Quintana, R. M. Beltran, I. Moreno, M. Wasserman, and G. Rodriguez. 1986. The use of rifampin and isoniazid entrapped in liposomes for the treatment of murine tuberculosis. Tubercle 67:91-97.
16. Pancholi, P., V. K. Vinayak, and G. K. Khuller. 1989. Immunogenicity of ribonucleic acid protein fraction of Mycobacterium tuberculosis encapsulated in liposomes. J. Med. Microbiol. 29:131-138.
17. Parthasarathy, R., R. G. Sarma, B. Janardhanam, P. Ramachandaran, T. Santha, S. Sivasubramanian, P. R. Somasundaram, and S. P. Tripathy. 1986. Hepatotoxicity in South Indian patients during treatment of tuberculosis with short course regimens containing isoniazid, rifampin and pyrazinamide. Tubercle 67:99-108.
18. Rastogi, N., and H. L. David. 1988. Mechanisms of pathogenicity in mycobacteria. Biochimie 70:1101-1120.
19. Saito, H., and H. Tomioka. 1989. Therapeutic efficacy of liposomal entrapped rifampin against Mycobacterium avium complex infection induced in mice. Antimicrob. Agents Chemother. 33:429-433.
20. Vladimirsky, M. A., and G. A. Ladigina. 1982. Antibacterial activity of liposome-entrapped streptomycin in mice infected with Mycobacterium tuberculosis. Biomed. Pharmacother. 36:375-377.
21. Wasserman, M., R. M. Beltran, F. O. Quintana, P. M. Mendoza, L. C. Orozco, and G. Rodriguez. 1986. A simple technique for the entrapment of rifampin and isoniazid into liposomes. Tubercle 67:83-90.